Testosterone MDL Judge Extends Requirements To Future Cases Against AbbVie

(November 29, 2018, 2:10 PM EST) -- CHICAGO — The judge overseeing the testosterone replacement therapy multidistrict litigation on Nov. 28 applied terms of an earlier case management order to plaintiffs who file future cases against defendant AbbVie Inc. and related defendants (In Re: Testosterone Replacement Therapy Products Liability Litigation, MDL Docket No. 2545, No. 14-1748, N.D. Ill.)....

Attached Documents

Related Sections